China: accelerated marketing of imported drugs

The China Food and Drug Administration (CFDA) is willing to authorize foreign laboratories to apply for a marketing authorization once international studies have been completed. The imported medicines could arrive on the market without having to undergo clinical trials again in China. A move which would stop many patients having to resort to the black market to gain access to innovative products!